BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31300947)

  • 1. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
    Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
    Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsequent neoplasms in childhood cancer survivors.
    Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
    Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
    Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
    J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Suicide among Cancer Survivors Who Developed a Second Malignant Neoplasm.
    Yang H; Qu Y; Shang Y; Wang C; Wang J; Lu D; Song H
    Comput Intell Neurosci; 2022; 2022():2066133. PubMed ID: 35047029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
    Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
    JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study.
    Teepen JC; Kok JL; Kremer LC; Tissing WJE; van den Heuvel-Eibrink MM; Loonen JJ; Bresters D; van der Pal HJ; Versluys B; van Dulmen-den Broeder E; Nijsten T; Hauptmann M; Hollema N; Dolsma WV; van Leeuwen FE; Ronckers CM;
    J Natl Cancer Inst; 2019 Aug; 111(8):845-853. PubMed ID: 30802904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
    Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
    Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
    J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
    Veiga LHS; Vo JB; Curtis RE; Mille MM; Lee C; Ramin C; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
    Lancet Oncol; 2022 Nov; 23(11):1451-1464. PubMed ID: 36240805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
    Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
    PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dose as a risk factor for malignant melanoma following childhood cancer.
    Guérin S; Dupuy A; Anderson H; Shamsaldin A; Svahn-Tapper G; Moller T; Quiniou E; Garwicz S; Hawkins M; Avril MF; Oberlin O; Chavaudra J; de Vathaire F
    Eur J Cancer; 2003 Nov; 39(16):2379-86. PubMed ID: 14556931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
    Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
    Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
    Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
    J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
    Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
    Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
    J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.